Skip to main content
. Author manuscript; available in PMC: 2019 Jun 13.
Published in final edited form as: Immunol Res. 2017 Dec;65(6):1103–1109. doi: 10.1007/s12026-017-8961-8

Table 2.

CSF levels of complement components in the MS and NMOSD

Complement
components
MS NMOSD References
RRMS PPMS SPMS
Classical
and lectin
pathways
C1q ↑
C3 ↑ in relapse ↓ in stable
C4a ↑
C4b ↑ in relapse
C3↑ C1q↑
C3↑
C3a – no difference
MBL/MASP2 – no difference
[20, 2225, 31]
Terminal
pathway
SC5b-9 ↑ N/A N/A C5a ↑ in relapse
SC5b-9 ↑ in relapse
[26, 31]
Inhibitors sCR2 ↑
Factor H ↓ in relapse
Factor H↑ sCR2↑
Factor H↑
N/A [20, 23, 29]